The separation will create one company focused on specialty branded pharmaceuticals, and another focused on specialty generic products and APIs manufacturing.
Walmart posted net income of $3.84 billion, or $1.33 a share, in the quarter ended April 26, up from $2.13 billion, or .72 cents a share from a year ago.
The increase is expected to leave many retailers in a crunch as they plan for the 2019 holiday season, scrambling to make purchase orders and set prices, CNBC reported.